Clinical Research

Mayo AI algorithm uses 3D body scans to predict risk of metabolic syndrome.

AI tool predicts metabolic disease using 3D body scans

Compared to standard hip-to-waist ratio measurements and BMI, the algorithm identifies significantly more instances of metabolic syndrome and its severity in individual patients.  

Ablation therapy versus partial nephrectomy for small renal masses

New findings portray both treatment options in a similar light when it comes to overall survival rates, though one creates significantly more burden for both patients and hospital resources. 

Thumbnail

Up to 25% of physically unresponsive patients are still conscious, imaging shows

The phenomenon, known as cognitive motor dissociation, might occur more often than previously believed.

Advanced imaging prompts treatment changes for nearly half of high-grade glioma patients

New research calls for greater utilization of advanced imaging in post-treatment protocols for patients with high-grade glioma.

The Shockwave Medical M5+ new peripheral intravascular lithotripsy (IVL) catheter cuts procedures times in half and was showed for the first time at the American College of Cardiology (ACC) 2022 meeting. It is designed to break up calcium in heavily calcified arteries to avoid the need for vessel trauma caused by high pressure angioplasty.

Intravascular lithotripsy, the technology at heart of $13B acquisition, linked to positive real-world data

The calcified plaque-shattering technology developed by Shockwave Medical continues to gain momentum. As more care teams start using IVL during PCI, researchers are paying close attention to its long-term impact on patient care.

Left atrial appendage occlusion (LAAO) with the Watchman FLX device from Boston Scientific is associated with positive outcomes and limited adverse events after one year, according to new findings published in Circulation: Cardiovascular Interventions.[1] Many prior Watchman FLX studies, including PINNACLE FLX, had focused on the device’s performance in a controlled setting. The study’s authors hoped to gain a better understanding of its real-world impact by reviewing registry data from more than 97,000 U.S

LAAO with Watchman FLX associated with positive 1-year outcomes, real-world data confirm

Researchers hoped to gain a better understanding of the device's real-world impact by reviewing registry data from more than 97,000 U.S. patients. Overall, the Watchman FLX was linked to positive data and limited adverse events one year after treatment. 

Study calls for MRI follow-up in concussion patients

Follow-up MRI in patients with mild traumatic brain injuries could help predict if they will experience lingering symptoms months later, even if their initial imaging was normal.

The J-Valve manufactured by JC Medical, a Genesis MedTech company, includes a self-expanding nitinol frame, bovine pericardial leaflets and three anchor rings designed to assist operators with alignment. Its delivery system was built with transfemoral access in mind, and JC Medical plans to offer the valve in five different sizes.

New TAVR valve for native aortic regurgitation linked to positive 30-day outcomes

The J Valve from JC Medical was linked to positive outcomes and “excellent” hemodynamic data after 30 days in an early feasibility study published in JACC: Cardiovascular Interventions. Researchers noted that the valve showed potential in patients with large aortic annuli, which represents an "unmet critical need" at this stage.